This inventor holds 1 USPTO granted patent. Top assignee: Yeditepe Üniversitesi. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Meltem Celik: Innovator in Cancer Treatment
Introduction
Meltem Celik is a prominent inventor based in Istanbul, Turkey. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. Her innovative work focuses on targeting specific enzymes that play a crucial role in cancer progression.
Latest Patents
Meltem Celik holds a patent for the compound 2-(3-(2-methyl-6-(p-tolyl) pyridine-3-yl) ureido) benzenesulfonamide and its derivatives. This compound serves as an inhibitor of carbonic anhydrase IX, which is essential for the treatment of cancer. The invention details a small molecule that targets carbonic anhydrase activity and its overexpression, making it a valuable pharmaceutical agent for combating proliferative diseases.
Career Highlights
Celik is affiliated with Yeditepe University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies, showcasing her dedication to advancing medical science.
Collaborations
Meltem collaborates with notable colleagues, including Fikrettin Sahin and Eslam Mohammed. These partnerships enhance her research capabilities and contribute to the innovative environment at Yeditepe University.
Conclusion
Meltem Celik is a trailblazer in the field of cancer treatment, with her patented compound offering promising avenues for future therapies. Her contributions to medical science reflect her commitment to improving patient outcomes through innovative research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile